Loading...
UK Trademark — IPO
GAT cbd-water
Application UK00917890818 · Registered
Quick Facts
| Application Number | UK00917890818 |
| Status | Registered |
| Owner | Gondwana Acquisition & Trust GmbH & Co. KG |
| Filed | 2018-04-24 |
| Registered | 2018-08-21 |
| Renewal Due | 2028-04-24 |
| Type | Individual |
| Feature | Figurative |
Is this trademark active?
Yes. GAT cbd-water is currently a registered UK trademark, with renewal due on 2028-04-24. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Diabetic fruit juice beverages adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic substances adapted for medical use; Dietetic foods adapted for invalids; Dietetic foods for use in clinical nutrition; Dietetic foods adapted for medical purposes; Medicinal drinks; Medicated food supplements; Preparations for use as additives to food for human consumption [medicated]; Mineral food supplements; Mineral dietary supplements for humans; Dietary supplemental drinks; Nutritional supplements; Food supplements; Dietary food supplements used for modified fasting; Mineral nutritional supplements; Dietary supplements consisting of vitamins; Dietary supplements for humans; Dietary supplements for humans not for medical purposes; Dietary supplements with a cosmetic effect; Dietary supplements for controlling cholesterol; Health food supplements for persons with special dietary requirements; Powdered nutritional supplement drink mix; Food for medically restricted diets; Natural dietary supplements for treating claustrophobia; By-products of the processing of cereals for dietetic or medical purposes; Food supplements for non-medical purposes; Prebiotic supplements; Probiotic supplements; Food for diabetics; Vitamin and mineral preparations; Vitamin and mineral supplements; Vitamin B preparations; Vitamin A preparations; Effervescent vitamin tablets; Vitamin C preparations; Vitamin D preparations; Vitamins and vitamin preparations; Vitamin drinks; Anti-cancer drugs; Antimigraine drugs; Medicines for human purposes; Medicines for intestinal disorders; Medicines for veterinary purposes; Antiseizure drugs; Medicines for prevention against milk fever; Autonomic drugs for medical purposes; Allergy relief medication; Sedatives; Biological adjuvants for medical purposes; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use; Elixirs for relieving chills; Elixirs for calming the skin; Elixirs for relieving asthma; Elixirs for preventing chills; Elixirs for preventing throat infections; Elixirs [pharmaceutical preparations]; Cardiovascular drugs used in treating arrhythmias; Cardiovascular preparations; Cardiotonics; Homeopathic pharmaceuticals; Homeopathic supplements; Pharmaceutical preparations containing caffeine; Caffeine preparations for medical use; Caffeine preparations for stimulative use; Herbal sprays for medical use; Tisanes [medicated beverages]; Herbal teas for medicinal purposes; Medical preparations for slimming purposes; Medicinal herb infusions; Medicinal sprays; Medicinal tea; Medicated throat sprays; Mouth sprays for medical use; Mouthwashes [gargles] for medical purposes; Muscle relaxants; Nasal drops for the treatment of allergies; Nervines; Anti-cancer preparations of plant origin; Anti-neoplastic preparations of plant origin; Cardiovascular pharmaceuticals; Pharmaceutical drugs; Ocular pharmaceuticals; Pharmaceutical cold preparations; Pharmaceuticals; Tissue-regenerative pharmaceutical preparations; Pharmaceutical products for the treatment of depression; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for hydrating the skin during pregnancy; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for treating chloasma; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for treating dry skin caused by pregnancy; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of kidney disorders; Pharmaceutical preparations for treating sports injuries; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for the prevention of allergies; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of disorders of the metabolic system; Pharmaceutical preparations for the prevention of disorders of the endocrine system; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of disorders of the genitourinary system; Pharmaceutical preparations for the prevention of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for treating the symptoms of radiation sickness; Pharmaceutical preparations for treating sensory organ disorders; Pharmaceutical preparations for the treatment of disorders of the endocrine system; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating digestive system disorders; Pharmaceutical preparations for the prevention of ocular disorders; Pharmaceutical preparations for the prevention of ocular diseases; Pharmaceutical preparations for the prevention of diseases of the endocrine system; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for the prevention of diseases of the metabolic system; Pharmaceutical agents affecting peripheral nervous system; Dermatological pharmaceutical substances; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents for treating physically caused lesions; Preparations for the treatment of asthma; Compounds for treating respiratory diseases; Preparations for treating colds; Anti-cancer preparations; Anti-cancer preparations from hormones and antagonists; Migraine treatment preparations; Compounds for treating cancer; Non-prescription medicines; Antimicrobial mouthwashes; Antiseptic mouthwashes; Pharmaceutical preparations for dental use; Dental rinse.
Class 32 — Non-Alcoholic Beverages
Non-alcoholic flavored carbonated beverages; Non-alcoholic soda beverages flavoured with tea; Fruit flavored soft drinks; Low-calorie soft drinks; Cola drinks; Aerated juices; Carbonated non-alcoholic drinks; Lemonades; Cola; Pastilles for effervescing beverages; Powders for effervescing beverages; Essences for making beverages; Preparations for making aerated water; Essences for making non-alcoholic drinks, not in the nature of essential oils; Essences for making flavoured mineral water [not in the nature of essential oils]; Extracts of unfermented must; Extracts for making beverages; Concentrates for making fruit drinks; Concentrates for use in the preparation of soft drinks; Powders used in the preparation of soft drinks; Syrups for making beverages; Syrups for beverages; Syrups for making soft drinks; Syrups for making whey-based beverages; Syrups for making fruit-flavored drinks; Syrups for making flavoured mineral waters; Syrups for making non-alcoholic beverages; Squashes [non-alcoholic beverages]; Dilutable preparations for making beverages.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 25.05.95 — Ornamental motifs, surfaces or backgrounds with ornaments
- 26.11.13 — Geometrical figures and solids
- 29.01.04 — Colours
Timeline
- Filed: 2018-04-24
- Registered: 2018-08-21
- Renewal due: 2028-04-24
About This Trademark
'GAT cbd-water' is a registered trademark on the UK IPO register, owned by Gondwana Acquisition & Trust GmbH & Co. KG. The application (UK00917890818) was filed on 24 April 2018 and registered on 21 August 2018. The registration is set to expire on 24 April 2028.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 32 (beers & non-alcoholic beverages).
Frequently Asked Questions
Who owns UK trademark UK00917890818 ('GAT cbd-water')?
UK trademark UK00917890818 for the mark 'GAT cbd-water' in Class 5, 32 is recorded on the UK IPO register as owned by Gondwana Acquisition & Trust GmbH & Co. KG. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00917890818 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00917890818 for the mark 'GAT cbd-water' as registered.
Which Nice classes is UK trademark UK00917890818 registered under?
UK trademark UK00917890818 for the mark 'GAT cbd-water' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 32 (beers & non-alcoholic beverages). The filed specification reads: Class 5: Diabetic fruit juice beverages adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic substances adapted for medical use; Dietetic foods adapted for invalids; Dietetic foods for use in clinical nutrition; Dietetic foods adapted for medical purposes; Medicinal drinks; Medicat…
When was UK trademark UK00917890818 filed?
UK trademark UK00917890818 for the mark 'GAT cbd-water' was filed at the UK IPO on 24 April 2018 and registered on 21 August 2018.
When does UK trademark UK00917890818 need to be renewed?
UK trademark UK00917890818 for the mark 'GAT cbd-water' is currently recorded as valid until 24 April 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.